Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 8, 2013, Pages 1207-1216

  Zhang, Xiaoli ^a   Xu, Luan ^a   Shen, Jianmin ^a,b   Cao, Bei ^c   Cheng, Ting ^a   Zhao, Tong ^a   Liu, Xiaoyan ^a   Zhang, Haixia ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer (EC); Focused metabolomics; Metabolomics; Proton nuclear magnetic resonance (1H NMR); Ultra high performance liquid chromatography (UHPLC)

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; AMINO ACID; CREATINE; CREATININE; GLUCOSE; GLUTAMIC ACID; LACTIC ACID; LIPID; LOW DENSITY LIPOPROTEIN; MEPYRAMINE MALEATE; TRICARBOXYLIC ACID; TYROSINE; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ACCURACY; ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE MARKER; ENERGY METABOLISM; ESOPHAGUS CANCER; FEMALE; GLYCOLYSIS; HUMAN; KETOGENESIS; LIPID METABOLISM; MALE; MEDICAL RESEARCH; METABOLIC DISORDER; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACIDS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENERGY METABOLISM; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOLYSIS; HUMANS; LIPID METABOLISM; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROGNOSIS; SERUM; TRICARBOXYLIC ACIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877359958     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.03.009     Document Type: Article

References (56)

1. American Cancer Society Global Cancer Facts & Figures 2011, American Cancer Society, Atlanta. 2nd Edition.
2. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 2003, 53:5-26.
3. Ajani J.A. Carcinoma of the esophagus: is biology screaming in my deaf ears. J. Clin. Oncol. 2005, 23:4256-4258.
4. Ruol A., Castoro C., Portale G., Cavallin F., Sileni V.C., Cagol M., Alfieri R., Corti L., Boso C., Zaninotto G., Peracchia A., Ancona E. Trends in management and prognosis for esophageal cancer surgery. Arch. Surg. 2009, 144:247-254.
5. Groome M., Lindsay J., Ross P.E., Cotton J.P., Hupp T.R., Dillon J.F. Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagus. Eur. J. Gastroenterol. Hepatol. 2008, 20:961-965.
6. Wakatsuki M., Suzuki Y., Nakamoto S., Ohno T., Ishikawa H., Kiyohara H., Kiyozuka M., Shirai K., Nakayama Y., Nakano T. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. J. Gastroenterol. Hepatol. 2007, 22:715-719.
7. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1:153-161.
8. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
9. Ebbels T.M.D., Keun H.C., Beckonert O.P., Bollard M.E., Lindon J.C., Holmes E., Nicholson J.K. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res. 2007, 6:4407-4422.
10. Lenz E.M., Wilson I.D. Analytical strategies inmetabonomics. J. Proteome Res. 2007, 6:443-458.
11. Zhang A.H., Sun H., Wang P., Han Y., Wang X.J. Recent and potential developments of biofluid analyses in metabolomics. J. Proteomics 2012, 75:1079-1088.
12. 1H NMR spectroscopy. J. Proteome Res. 2007, 6:3456-3464.
13. 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Anal. Chim. Acta 2005, 542:169-177.
14. 1H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. Biochim. Biophys. Acta Mol. Basis Dis. 2011, 1812:1371-1379.
15. Banday K.M., Pasikanti K.K., Chan E.C.Y., Singla R., Rao K.V.S., Chauhan V.S., Nanda R.K. Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal. Chem. 2011, 83:5526-5534.
16. Ciborowski M., Rupérez F.J., Martĺnez-Alcázar M., Angulo S., Radziwon P., Olszanski R., Kloczko J., Barbas C. Metabolomic approach with LC-MS reveals significant effect of pressure on diver's plasma. J. Proteome Res. 2010, 9:4131-4137.
17. Geier F.M., Want E.J., Leroi A.M., Bundy J.G. Cross-platform comparison of Caenorhabditis elegans tissue extraction strategies for comprehensive metabolome coverage. Anal. Chem. 2011, 83:3730-3736.
18. Wu H., Xue R.Y., Lu C.L., Deng C.H., Liu T.T., Zeng H.Z., Wang Q. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J. Chromatogr. B 2009, 877:3111-3117.
19. Ikeda A., Nishiumi S., Shinohara M., Yoshie T., Hatano N., Okuno T., Bamba T., Fukusaki E., Takenawa T., Azuma T., Yoshida M. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed. Chromatogr. 2012, 26:548-558.
20. Nishiumi S., Shinohara M., Atsuki I., Yoshie T., Hatano N., Kakuyama S., Mizuno S., Sanuki T., Kutsumi H., Fukusaki E. Serum metabolomics as a novel approach for pancreatic cancer. Metabolomics 2010, 6:518-528.
21. Pasikanti K.K., Esuvaranathan K., Ho P.C., Mahendran R., Kamaraj R., Wu Q.H., Chiong E., Chan E.C.Y. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J. Proteome Res. 2010, 9:2988-2995.
22. Rocha C.M., Carrola J., Barros A.S., Gil A.M., Goodfellow B.J., Carreira I.M., Bernardo J., Gomes A., Sousa V., Carvalho L., Duarte I.F. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J. Proteome Res. 2011, 10:4314-4324.
23. Wedge D.C., Allwood J.W., Dunn W., Vaughan A.A., Simpson K., Brown M., Priest L., Blackhall F.H., Whetton A.D., Dive C., Goodacre R. Is serum or plasma more appropriate for intersubject comparisons in metabmolomic studies? An assessment in patients with small-cell lung cancer. Anal. Chem. 2011, 83:6689-6697.
24. Blaise B.J., Shintu L., Elena B., Emsley L., Dumas M.E. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. Anal. Chem. 2009, 81:6242-6251.
25. Griffiths W.J., Ogundare M., Williams C.M., Wang Y. On the future of "omics": lipidomics. J. Inherit. Metab. Dis. 2011, 34:583-592.
26. Dong J., Cai X., Zhao L., Xue X., Zou L., Zhang X., Liang X. Lysophosphatidylcholines profiling of plasma discrimination of isomers and discovery of lung cancers biomarkers. Metabolomics 2010, 6:478-488.
27. Koo H., Wallig M.A., Chung B.H., Nara T.Y., Cho B.H.S., Nakamura M.T. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim. Biophys. Acta Mol. Basis Dis. 2008, 1782:341-348.
28. Yuan X., Yan S., Zhao J., Shi D., Yuan B., Dai W., Miao M. Lipid metabolism and peroxisome proliferator-activated receptor signaling pathways participate in late-phase liver regeneration. J. Proteome Res. 2011, 10:1179-1190.
29. Yuan W., Zhang J.X., Li S.W., Edwards J.L. Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging. J. Proteome Res. 2011, 10:5242-5250.
30. Kimura T., Noguchi Y., Shikata N., Takahashi M. Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:49-53.
31. Yakoub D., Keun H.C., Goldin R., Hanna G.B. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer. Cancer Res. 2010, 70:9129-9136.
32. Zhang J., Bowers J., Liu L.Y., Wei S.W., Gowda G.A.N., Hammoud Z., Raftery D. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One 2012, 7:e30181.
33. Blekherman G., Laubenbacher R., Cortes D.F., Mendes P., Torti F.M., Akman S., Torti S.V., Shulaev V. Bioinformatics tools for cancer metabolomics. Metabolomics 2011, 7:329-343.
34. Rousseau R., Govaerts B., Verleysen M., Boulanger B. Comparison of some chemometric tools for metabonomics biomarker identification. Chemom. Intell. Lab. Syst. 2008, 91:54-66.
35. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6:469-479.
36. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002, 16:119-128.
37. Bylesjo M., Eriksson D., Sjodin A., Jansson S., Moritz T., Trygg J. Orthogonal projections to latent structures as a strategy for microarray data normalization. BMC Bioinform. 2007, 8:207.
38. Lindgren F., Hansen B., Karcher W., Sjöström M., Eriksson L. Model validation by permutation tests: applications to variable selection. J. Chemom. 1996, 10:521-532.
39. Eriksson L., Trygg J., Wold S. CV-ANOVA for significance testing of PLS and OPLS (R) models. J. Chemom. 2008, 22:594-600.
40. Chong I.G., Jun C.H. Performance of some variable selection methods when multicollinearity is present. Chemom. Intell. Lab. Syst. 2005, 78:103-112.
41. Quintas G., Portillo N., García-Cañaveras J.C., Castell J.V., Ferrer A., Lahoz A. Chemometric approaches to improve PLS-DA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool. Metabolomics 2012, 8:86-98.
42. Zheng P., Gao H.C., Li Q., Shao W.H., Zhang M.L., Cheng K., Yang D.Y., Fan S.H., Chen L., Fang L., Xie P. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J. Proteome Res. 2012, 11:1741-1748.
43. Zhang X.Y., Wang Y.L., Hao F.H., Zhou X.H., Han X.Y., Tang H.R., Ji L.N. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J. Proteome Res. 2009, 8:5188-5195.
44. 1H-nuclear magnetic resonance. J. Proteome Res. 2010, 9:5180-5187.
45. Zhang X., Zhao T., Cheng T., Liu X., Zhang H. J. Chromatogr. B 2012, 906:91-95.
46. Passarella S., Bari L., Valenti D., Pizzuto R., Paventi G., Atlante A. Mitochondria and l-lactate metabolism. FEBS Lett. 2008, 582:3569-3576.
47. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis. Nat. Rev. Cancer 2004, 4:891-899.
48. Bathen T.F., Engan T., Krane J., Axelson D. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer. Res. 2000, 20:2393-2408.
49. McGarry J.D., Foster D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 1980, 49:395-420.
50. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 2000, 80:1107-1213.
51. Newsholme P., Lima M.M.R., Procopio J., Pithon-Curi T.C., Doi S.Q., Bazotte R.B., Curi R. Glutamine and glutamate as vital metabolites. Braz. J. Med. Biol. Res. 2003, 36:153-163.
52. Inoue-Choi M., Nelson H.H., Robien K., Arning E., Bottiglieri T., Koh W., Yuan J.M. One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore. Int. J. Mol. Epidemiol. Genet. 2012, 3:160-173.
53. Fell D., Steele R.D. Effect of methionine on in vivo histidine metabolism in rats. J. Nutr. 1983, 113:860-866.
54. Holecek M., Sprongl L., Skopec F., Andrýs C., Pecka M. Leucine metabolism in TNF-alpha- and endotoxin-treated rats: contribution of hepatic tissue. Am. J. Physiol. 1997, 273:E1052-E1058.
55. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 1999, 375:87-100.
56. Barazzoni R., Zanetti M., Vettore M., Tessari P. Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans. Metabolism 1998, 47:669-674.